Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $746.50 | 40 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $301.02 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $126.54 | 7 | $0 (2024) |
| Lilly USA, LLC | $85.06 | 5 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $65.97 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $40.25 | 2 | $0 (2024) |
| Dexcom, Inc. | $39.95 | 2 | $0 (2023) |
| Tactile Systems Technology Inc | $25.33 | 1 | $0 (2024) |
| Novo Nordisk Inc | $19.55 | 1 | $0 (2024) |
| Axsome Therapeutics, Inc. | $15.21 | 1 | $0 (2023) |
| Alkermes, Inc. | $14.12 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $251.30 | 12 | ABBVIE INC. ($88.67) |
| 2023 | $109.86 | 6 | Otsuka America Pharmaceutical, Inc. ($33.25) |
| 2022 | $211.19 | 12 | ABBVIE INC. ($135.95) |
| 2021 | $174.15 | 10 | Lilly USA, LLC ($85.06) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: PSYCHIATRY | ||||||
| 09/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 04/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: PSYCHIATRY | ||||||
| 02/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Respiratory | ||||||
| 01/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Diabetes | ||||||
| 06/30/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: CNS | ||||||
| 06/23/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: PSYCHIATRY | ||||||
| 06/09/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Endocrinology | ||||||
| 04/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: PSYCHIATRY | ||||||
| 01/13/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/06/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Endocrinology | ||||||
| 12/02/2022 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 10/14/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: PSYCHIATRY | ||||||
| 08/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: PSYCHIATRY | ||||||
| 06/16/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 33 | 52 | $15,996 | $3,507 |
| 2022 | 2 | 35 | 43 | $9,410 | $1,980 |
| 2021 | 2 | 27 | 37 | $9,950 | $2,047 |
| 2020 | 8 | 354 | 8,347 | $205,067 | $47,480 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 35 | $12,168 | $2,635 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 17 | $3,827 | $871.47 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 28 | $8,960 | $1,959 | 21.9% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 15 | 15 | $450.00 | $21.08 | 4.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 19 | $6,080 | $1,514 | 24.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 18 | $3,870 | $532.15 | 13.8% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2020 | 13 | 925 | $31,450 | $12,356 | 39.3% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2020 | 14 | 6,720 | $36,019 | $11,923 | 33.1% |
| 64640 | Destruction of peripheral nerve or branch | Office | 2020 | 21 | 89 | $35,155 | $9,067 | 25.8% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2020 | 86 | 131 | $38,610 | $7,303 | 18.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 89 | 105 | $22,668 | $3,095 | 13.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 47 | 47 | $22,795 | $2,877 | 12.6% |
| 64450 | Injection of anesthetic agent and/or steroid into other peripheral nerve or branch | Office | 2020 | 21 | 22 | $6,050 | $560.98 | 9.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 63 | 308 | $12,320 | $298.19 | 2.4% |
About Daniel Tibbits
Daniel Tibbits is a Nurse Practitioner healthcare provider based in Grants Pass, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2012. The National Provider Identifier (NPI) number assigned to this provider is 1922356658.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Tibbits has received a total of $746.50 in payments from pharmaceutical and medical device companies, with $251.30 received in 2024. These payments were reported across 40 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($746.50).
As a Medicare-enrolled provider, Tibbits has provided services to 449 Medicare beneficiaries, totaling 8,479 services with total Medicare billing of $55,013. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Grants Pass, OR
- Active Since 08/28/2012
- Last Updated 02/15/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922356658
Products in Payments
- VRAYLAR (Drug) $252.21
- ABILIFY MAINTENA (Drug) $75.89
- TRINTELLIX (Drug) $65.97
- REXULTI (Drug) $50.65
- AIRSUPRA (Drug) $40.25
- Dexcom G6 Transmitter (Medical Supply) $39.95
- EMGALITY (Drug) $36.95
- UBRELVY (Drug) $36.61
- Flexitouch Plus (Device) $25.33
- TRULICITY (Drug) $20.30
- Ozempic (Drug) $19.55
- JARDIANCE (Drug) $16.19
- Auvelity (Drug) $15.21
- ARISTADA (Drug) $14.12
- KEVEYIS (Drug) $13.50
- VIIBRYD (Drug) $12.20
- REYVOW (Drug) $11.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Grants Pass
Laura Anderson, Dnp Aprn-Np, DNP APRN-NP
Nurse Practitioner — Payments: $513.22
Mrs. Rachael Montgomery
Nurse Practitioner — Payments: $68.58
Jessie Hermant, Fnp, FNP
Nurse Practitioner — Payments: $61.90
Roberta Bell, Np, NP
Nurse Practitioner — Payments: $11.41
Ms. Judith King, Cfnp, CFNP
Nurse Practitioner
Ms. Tammy Lowe, Fnp, FNP
Nurse Practitioner